Comments of DPR's RCD for Thiabendazole

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Thiabendazole. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.

Downloads

Comments of DPR's RCD for ThiabendazoleJan 1, 2000

Chemical Reference

• Thiabendazole